Discover 127 paid clinical trials in Billings, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 127
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Billings MT, Regina, Salt Lake City UT, Spokane WA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Location: Billings MT, Aurora CO, Puyallup WA, Phoenix AZ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06679101
Phase 3, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Get alerts for new trials in your area by subscribing now
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Billings MT, Portland OR, West Haven-Sylvan OR,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
for
Chemotherapy-induced Nausea and Vomiting
Location: Billings MT, Chandler AZ, Anaheim CA, Skokie IL,
Sponsor: Xiamen LP Pharmaceutical Co., Ltd
Sex: All
Age: 18+
Code: NCT05199818
Phase 3, Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Billings MT, Farmington UT, Salt Lake City UT,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase 2, Recruiting
Multi-Institutional Registry for Prostate Cancer Radiosurgery
for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Billings MT, Great Falls MT, Missoula MT,
Sponsor: RPCR, Inc.
Sex: Male
Age: 18 - 70+
Code: NCT01226004
Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
for
Melanoma Stage IV, Solid Tumor
Location: Billings MT, Scottsdale AZ, San Francisco CA,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06425926
Phase 1, Phase 2, Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
for
Non-small Cell Lung Cancer
Location: Billings MT, Winnipeg, Kansas City MO, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06345729
Phase 3, Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Billings MT, Omaha NE, Santa Fe NM, Las Vegas NV,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06295731
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Billings MT, Salt Lake City UT, Seattle WA, Portland OR,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Billings MT, Boise ID, Meridian ID, Nampa ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04840602
Phase 2, Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Billings MT, Ogden UT, Fort Collins CO, Boise ID,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Location: Billings MT, Spokane WA, Palo Alto CA, Anaheim CA,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05254743
Phase 3, Recruiting
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Billings MT, Sacramento CA, Dallas TX, Austin TX,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT06933329
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,